ResearcherUniversity of Nebraska Medical CenterNo recent work listed

Chitra Palanivel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3379-2695; OpenAlex author ID A5032846820. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2022: 1 paper

Papers 1

The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells. Co-author DOI 10.1016/j.neo.2022.01.002 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Parthasarathy Seshacharyulu · 1 shared paper, 2022 · strength 0.17
- Paper The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic can… DOI 10.1016/j.neo.2022.01.002 ↗
Jesse L. Cox · 1 shared paper, 2022 · strength 0.17
- Paper The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic can… DOI 10.1016/j.neo.2022.01.002 ↗
Neha Chaudhary · 1 shared paper, 2022 · strength 0.17
- Paper The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic can… DOI 10.1016/j.neo.2022.01.002 ↗
Ying Yan · 1 shared paper, 2022 · strength 0.17
- Paper The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic can… DOI 10.1016/j.neo.2022.01.002 ↗
Surinder K. Batra · 1 shared paper, 2022 · strength 0.17
- Paper The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic can… DOI 10.1016/j.neo.2022.01.002 ↗
Michel M. Ouellette · 1 shared paper, 2022 · strength 0.17
- Paper The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic can… DOI 10.1016/j.neo.2022.01.002 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.